Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven Approach.

ADNI Alzheimer's disease biomarkers deep learning longitudinal magnetic resonance imaging progression

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2019
Historique:
received: 04 07 2019
accepted: 19 09 2019
entrez: 23 10 2019
pubmed: 23 10 2019
medline: 23 10 2019
Statut: epublish

Résumé

Alzheimer's disease (AD) is the most common neurodegenerative disorder worldwide and is one of the leading sources of morbidity and mortality in the aging population. There is a long preclinical period followed by mild cognitive impairment (MCI). Clinical diagnosis and the rate of decline is variable. Progression monitoring remains a challenge in AD, and it is imperative to create better tools to quantify this progression. Brain magnetic resonance imaging (MRI) is commonly used for patient assessment. However, current approaches for analysis require strong a priori assumptions about regions of interest used and complex preprocessing pipelines including computationally expensive non-linear registrations and iterative surface deformations. These preprocessing steps are composed of many stacked processing layers. Any error or bias in an upstream layer will be propagated throughout the pipeline. Failures or biases in the non-linear subject registration and the subjective choice of atlases of specific regions are common in medical neuroimaging analysis and may hinder the translation of many approaches to the clinical practice. Here we propose a data-driven method based on an extension of a deep learning architecture, DeepSymNet, that identifies longitudinal changes without relying on prior brain regions of interest, an atlas, or non-linear registration steps. Our approach is trained end-to-end and learns how a patient's brain structure dynamically changes between two-time points directly from the raw voxels. We compare our approach with Freesurfer longitudinal pipelines and voxel-based methods using the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Our model can identify AD progression with comparable results to existing Freesurfer longitudinal pipelines without the need of predefined regions of interest, non-rigid registration algorithms, or iterative surface deformation at a fraction of the processing time. When compared to other voxel-based methods which share some of the same benefits, our model showed a statistically significant performance improvement. Additionally, we show that our model can differentiate between healthy subjects and patients with MCI. The model's decision was investigated using the epsilon layer-wise propagation algorithm. We found that the predictions were driven by the pallidum, putamen, and the superior temporal gyrus. Our novel longitudinal based, deep learning approach has the potential to diagnose patients earlier and enable new computational tools to monitor neurodegeneration in clinical practice.

Identifiants

pubmed: 31636533
doi: 10.3389/fnins.2019.01053
pmc: PMC6788344
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1053

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States

Informations de copyright

Copyright © 2019 Pena, Barman, Suescun, Jiang, Schiess, Giancardo and the Alzheimer's Disease Neuroimaging Initiative.

Références

Neuroimage. 2017 Jan 15;145(Pt B):166-179
pubmed: 27989847
J Gerontol. 1982 May;37(3):323-9
pubmed: 7069156
Sci Rep. 2017 Jan 12;7:39880
pubmed: 28079104
Acta Neuropathol. 2016 Apr;131(4):571-85
pubmed: 26810071
Neurobiol Aging. 2000 Jan-Feb;21(1):19-26
pubmed: 10794844
PLoS One. 2016 Feb 22;11(2):e0138866
pubmed: 26901338
Neuroimage. 2011 Apr 1;55(3):856-67
pubmed: 21236349
Neuroimage. 2019 Apr 1;189:276-287
pubmed: 30654174
Sci Data. 2016 Jun 21;3:160044
pubmed: 27326542
Neuroimage Clin. 2017 Nov 09;17:628-641
pubmed: 29234599
J Cogn Neurosci. 2010 Dec;22(12):2677-84
pubmed: 19929323
Neuroimage. 2010 Dec;53(4):1181-96
pubmed: 20637289
Neuroimage. 2018 Feb 15;167:62-72
pubmed: 29155080
Front Neurosci. 2019 Jan 09;12:967
pubmed: 30686966
PLoS One. 2012;7(3):e33182
pubmed: 22457741
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
Eur J Neurol. 2018 Jan;25(1):59-70
pubmed: 28872215
Clin Interv Aging. 2017 Jun 29;12:1041-1048
pubmed: 28721032
PLoS One. 2017 Mar 6;12(3):e0173372
pubmed: 28264071
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
Med Image Anal. 2019 Apr;53:39-46
pubmed: 30682584
Alzheimers Dement. 2017 Apr;13(4):e1-e85
pubmed: 28342697
Neuroimage. 2017 Jul 15;155:530-548
pubmed: 28414186
Neuroimage. 2018 Dec;183:504-521
pubmed: 30130647
Comput Methods Programs Biomed. 2018 May;158:113-122
pubmed: 29544777
J Cogn Neurosci. 1996 Nov;8(6):566-87
pubmed: 23961985
Neuroimage. 2012 Mar;60(1):221-9
pubmed: 22236449
Curr Alzheimer Res. 2015;12(5):493-502
pubmed: 26017560
Front Neuroinform. 2017 Feb 24;11:16
pubmed: 28286479
Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:1941-4
pubmed: 25570360
J Alzheimers Dis. 2020;76(4):1461-1475
pubmed: 32651312
Neurosci Lett. 2010 Jan 4;468(2):146-50
pubmed: 19879920
Neurobiol Aging. 2017 Aug;56:172-179
pubmed: 28552181
BMC Med Imaging. 2014 Jun 02;14:21
pubmed: 24889999
Med Image Comput Comput Assist Interv. 2016 Oct;9901:70-78
pubmed: 28580458
Front Hum Neurosci. 2015 Sep 08;9:474
pubmed: 26441584
Comput Methods Programs Biomed. 2017 Oct;150:1-8
pubmed: 28859825
Med Image Anal. 2017 Dec;42:60-88
pubmed: 28778026
Alzheimers Dement (Amst). 2018 Aug 11;10:519-535
pubmed: 30364671
PLoS One. 2015 Jul 10;10(7):e0130140
pubmed: 26161953
Neuroimage. 2019 Feb 1;186:518-532
pubmed: 30471388
J Alzheimers Dis. 2017;59(4):1359-1379
pubmed: 28759968
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Alzheimers Res Ther. 2017 Aug 9;9(1):60
pubmed: 28793924
PLoS One. 2014 Aug 06;9(8):e102312
pubmed: 25098835
Neuroimage. 2016 Nov 1;141:542-555
pubmed: 27426838
Int J Biomed Imaging. 2018 Mar 15;2018:1247430
pubmed: 29736165
PLoS Comput Biol. 2018 Sep 14;14(9):e1006376
pubmed: 30216352

Auteurs

Danilo Pena (D)

School of Biomedical Informatics, University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Center for Precision Health, UTHealth, Houston, TX, United States.

Arko Barman (A)

School of Biomedical Informatics, University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Center for Precision Health, UTHealth, Houston, TX, United States.

Jessika Suescun (J)

Department of Neurology, McGovern Medical School, UTHealth, Houston, TX, United States.

Xiaoqian Jiang (X)

School of Biomedical Informatics, University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.

Mya C Schiess (MC)

Department of Neurology, McGovern Medical School, UTHealth, Houston, TX, United States.

Luca Giancardo (L)

School of Biomedical Informatics, University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.
Center for Precision Health, UTHealth Diagnostic and Interventional Imaging, McGovern Medical School, UTHealth Institute for Stroke and Cerebrovascular Diseases, UTHealth, Houston, TX, United States.

Classifications MeSH